Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn’s disease in Japan (SPREAD-J study)
Journal of Gastroenterology · 2023
DOI: 10.1007/s00535-023-02017-3 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2023. Verfasst von Toshiyuki Sakurai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minat…. Hauptthemen laut MEDLINE: Crohn Disease, Capsule Endoscopy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Evidence of small-bowel capsule endoscopy (SBCE) for evaluating lesions in Crohn’s disease (CD) is lacking. We aimed to clarify the effectiveness and safety of SBCE in a large sample of patients with CD.
Methods
This multicenter prospective registration study recorded the clinical information and SBCE results of patients with definitive CD (d-CD) or suspected CD (s-CD). The primary outcomes were the rates of successful assessment of disease activity using SBCE, definitive diagnosis of CD, and adverse events. Secondary outcomes were the assessment of SBCE findings in patients with d-CD and s-CD and factors affecting SBCE incompletion and retention; and tertiary outcomes included the association between clinical disease activity or blood examination, endoscopic disease activity, ileal CD, and the questionnaire assessment of patient acceptance of SBCE.
Results
Of 544 patients analyzed, 541 underwent SBCE with 7 (1.3%) retention cases. Of 468 patients with d-CD, 97.6% could be evaluated for endoscopic activity. Of 76 patients with s-CD, 15.8% were diagnosed with ‘confirmed CD’. CD lesions were more frequently observed in the ileum and were only seen in the jejunum in 3.4% of the patients. Male sex and stenosis were risk factors for incomplete SBCE, and high C-reactive protein levels and stenosis were risk factors for capsule retention. In L1 (Montreal classification) patients, clinical remission was associated with endoscopic remission but showed low specificity and accuracy. The answers to the acceptability questionnaire showed the minimal invasiveness and tolerability of SBCE.
Conclusion
SBCE is practical and safe in patients with CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
- Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
- Sapporo IBD Clinic, Yamahana Doctor Town F2, 1-18, Minami-19, Nishi-8, Chuo-ku, Sapporo, Hokkaido, 064-0919, Japan.
- Inflammatory Bowel Disease Center, Sapporo Higashi Tokushukai Hospital, N33-E14, Higashi-ku, Sapporo, Hokkaido, 065-0033, Japan.
- Gastroenterology and Endoscopy, Division of Metabolism and Biosystemic Science, Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 1-1-1, Higashi-nizyo, Midorigaoka, Asahikaw…
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
ORCID-Profile: Masayuki Saruta
Zitieren
APA
Sakurai, T., Omori, T., Tanaka, H., Ito, T., Ando, K., Yamamura, T., Nanjjo, S., Osawa, S., Takeda, T., Watanabe, K., Hiraga, H., Yamamoto, S., Ozeki, K., Tanaka, S., Tajiri, H., Saruta, M., & SPREAD-J group (2023). Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn’s disease in Japan (SPREAD-J study). Journal of Gastroenterology. https://doi.org/10.1007/s00535-023-02017-3
Vancouver
Sakurai T, Omori T, Tanaka H, Ito T, Ando K, Yamamura T, et al. Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn’s disease in Japan (SPREAD-J study). Journal of Gastroenterology. 2023. doi:10.1007/s00535-023-02017-3
BibTeX
@article{Sakurai2023,
author = {Sakurai, Toshiyuki and Omori, Teppei and Tanaka, Hiroki and Ito, Takahiro and Ando, Katsuyoshi and Yamamura, Takeshi and Nanjjo, Sohachi and Osawa, Satoshi and Takeda, Teruyuki and Watanabe, Kenji and Hiraga, Hiroto and Yamamoto, Shuji and Ozeki, Keiji and Tanaka, Shinji and Tajiri, Hisao and Saruta, Masayuki and SPREAD-J group, SPREAD-J group},
title = {Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn’s disease in Japan (SPREAD-J study)},
journal = {Journal of Gastroenterology},
year = {2023},
doi = {10.1007/s00535-023-02017-3}
}
EUVIMED